RDCD Stock Overview
Operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Redcare Pharmacy NV Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €136.30 |
| 52 Week High | €163.15 |
| 52 Week Low | €117.40 |
| Beta | 0.97 |
| 1 Month Change | -7.37% |
| 3 Month Change | 16.10% |
| 1 Year Change | 0.85% |
| 3 Year Change | 9.13% |
| 5 Year Change | 209.77% |
| Change since IPO | 249.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| RDCD | GB Consumer Retailing | GB Market | |
|---|---|---|---|
| 7D | -15.5% | -2.4% | -2.6% |
| 1Y | 0.9% | 9.0% | 2.4% |
Return vs Industry: RDCD underperformed the UK Consumer Retailing industry which returned 8.5% over the past year.
Return vs Market: RDCD underperformed the UK Market which returned 2.7% over the past year.
Price Volatility
| RDCD volatility | |
|---|---|
| RDCD Average Weekly Movement | n/a |
| Consumer Retailing Industry Average Movement | 3.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.7% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine RDCD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,900 | Olaf Heinrich | www.redcare-pharmacy.com |
Redcare Pharmacy NV operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023.
Redcare Pharmacy NV Fundamentals Summary
| RDCD fundamental statistics | |
|---|---|
| Market cap | €2.77b |
| Earnings (TTM) | -€24.56m |
| Revenue (TTM) | €2.23b |
1.2x
P/S Ratio-112.8x
P/E RatioIs RDCD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RDCD income statement (TTM) | |
|---|---|
| Revenue | €2.23b |
| Cost of Revenue | €1.71b |
| Gross Profit | €516.65m |
| Other Expenses | €541.21m |
| Earnings | -€24.56m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.21 |
| Gross Margin | 23.20% |
| Net Profit Margin | -1.10% |
| Debt/Equity Ratio | 45.6% |
How did RDCD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 14:21 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Redcare Pharmacy NV is covered by 26 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Volker Bosse | Baader Helvea Equity Research |
| Gerhard Schwarz | Baader Helvea Equity Research |
| Alvira Rao | Barclays |